Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-11-13

Clinical Trial Update: Effects of a rapamycIn-eluting carboNized Stent With a Completely biodEgradable polymeR Coating

View source ↗

Summary

Clinical trial update on a rapamycin-eluting carbonized stent with a completely biodegradable polymer coating for coronary artery disease. The current status of…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sirolimus (Sirolimus)

Snippet

Sponsor: University of Roma La Sapienza | Conditions: Coronary Artery Disease | Status: UNKNOWN